560075-65-2

Usage

Uses

Used in Pharmaceutical Industry:
2,6-Dichloro-N-(4-chlorophenyl)-benzeneacetamide is used as an impurity in the production of Diclofenac (D436450), a nonsteroidal anti-inflammatory compound. Its presence is significant as it can impact the quality, safety, and efficacy of the final drug product. The pharmaceutical industry is responsible for monitoring and controlling the levels of this impurity to ensure the therapeutic benefits of Diclofenac are not compromised.
Additionally, understanding the properties and effects of this impurity can contribute to the development of new drugs or modifications to existing ones, potentially leading to improved treatments for various inflammatory conditions.
Used in Research and Development:
In the field of medicinal chemistry and pharmaceutical research, 2,6-Dichloro-N-(4-chlorophenyl)-benzeneacetamide serves as a subject of study for understanding the structure-activity relationship (SAR) of NSAIDs and COX inhibitors. Researchers may investigate its chemical properties, interactions with biological targets, and potential effects on inflammation and pain relief. This knowledge can be applied to design more effective and safer drugs for treating conditions such as arthritis, musculoskeletal disorders, and other inflammatory diseases.
Used in Quality Control and Regulatory Compliance:
2,6-Dichloro-N-(4-chlorophenyl)-benzeneacetamide is also relevant in the context of quality control and regulatory compliance within the pharmaceutical industry. Regulatory agencies require drug manufacturers to demonstrate that their products are free from harmful impurities or that these impurities are within acceptable limits. As a known impurity of Diclofenac, 2,6-Dichloro-N-(4-chlorophenyl)-benzeneacetaMide is subject to strict quality control measures and must be monitored and managed accordingly to meet regulatory standards and ensure patient safety.